research and patient care at The Neuro

Neuro National Clinical Trial Training Program

May 28 & 29, 2020

The Neuro's Clinical Research Unit (CRU), will hold its 4th Annual Neuro National Clinical Trial Training Program on May 28 & 29, 2020.  Principal investigators, researchers, clinical research coordinators, and representatives from industry are invited to attend this two-day program covering education and training on: clinical trial readiness, medical monitoring, CROs, novel technology in clinical trials, consortium trials, trial design, drug safety, clinical trial outcome measures, and more. Past keynote speakers have included representatives from the pharmaceutical industry, small biotech, CRO representatives, Health Canada, and leading investigators in neurology and rare disease.

The CRU, under the direction of Dr. Angela Genge, is involved in over 100 clinical trials in all fields of neuroscience. Its teams are experienced in Phase I-IV clinical trials, Investigator-initiated trials, bio-banking, and patient registries. The CRU has a unique model, employing specialized personnel in each of the major areas of clinical site management which encompasses finance, ethics, biological sample processing, coordination, nursing, and medical writing.

Registration will be available soon.

Welcome Event

May 27, 2020
6-10 PM
Pointe-à-Callière Museum, 350 rue Place Royale, Montreal Cocktail - Dinatoire + Museum tour

Program Day 1

8

Continental Breakfast

de Grandpré Communications Centre

8:30

Welcoming Remarks
Angela Genge, MD, FRCP Director, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada

8:45 Development Path of the Raman Probe Technology
Christopher Kent, PhD President & CEO
ODS Medical, Canada
9:15 Modelling disorders of the brain through stem cells
Thomas Durcan, PhD
Assistant Professor
Montreal Neurological Institute and Hospital, Canada
9:45 A tale of two worlds : investment & entrepreneurship in diagnostics
Marie-Claude Marchand, BSc, MBA
Senior Advisor
TVM Life Science Management Inc., Canada
10:15 Panel - Q & A
10:30 Refreshment break
10:45 Consortiums & Clinical Trials
Leonard van den Berg, MD
Professor of Neurology
Director Netherlands ALS Center
Chair of ENCALS University Medical Center
Utrecht, Netherlands
11:15

The Chorus Model: The Benefits of Therapeutic Cross-Pollination Design
Robert Schott, MD, MPH, FAAC
Chief Medical Officer
Lilly - Chorus, USA

11:45 An Entrepreneur's Guide to Addressing Unmet Medical Needs
Jim Callaway, PhD
CEO KalGene Pharmaceuticals, Canada
12:15 Panel - Q & A
12:30 Lunch
13:30 Medical Monitoring in Clinical Trials
Jinsy Andrews, MD, MSc.
Assistant Professor of Neurology
Columbia University, USA
14 The Art and Science of Early Stage Clinical Safety - From Entry into Human to Phase 2 studies
Joshua Galanter, MD, MAS
Safety Science
Associated Medical Director
LEAD/Early Development Safety Genentech Inc., USA
14:30 Ethics of Al & Gene Therapy Research in Medicine
Marie Hirtle, LLB, LLM
Manager Center of Applied Ethics - MUHC, Canada
15 Panel Q & A
15:15 Refreshment break
15:30 CIHR Initiatives that support drug development
Martine Lafrance, PhD
Manager of Program Design & Delivery Programs
Canadian Institutes of Health Research (CIHR), Canada
16

Patients before costs: A balanced approach to drug development
Daria Wojtal, PhD
Director of Research
Muscular Dystrophy Canada

Marie-Hélène Bolduc Director of Mission Muscular Dystrophy Canada

16:30

Regulation of Regenerative Medicines in Canada – Overview of the Regulatory Framework for Cell and Gene Therapies
Nadine Kolas, PhD
Senior Policy Analyst
Policy & International Collaboration
Health Canada

17 Panel Q & A
17:15 Closing Remarks & Discussion
Dr. Angela Genge
18 Dinner - Joiea Sociale, 656 Wellington Street, Montréal

Program Day 2

8:30

Continental Breakfast

9 Welcoming Remarks
Angela Genge, MD, FRCP
Director, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada
9:15 Drug Development in the Digital Age - A Perspective on Neuroscience
Norman Putzki, MD, PhD
Vice President Global Drug Development
Novartis Pharma AG, USA
9:45 CRO-Sponsor Relationships
Ignazio Di Giovanna, PhD
Vice President, European Operations
Atlantic Research Group
10:15 New tech in trials
Jesse Cedarbaum, MD
Vice President, Neurology Early Clinical Development
Biogen Idec, USA
10:45 Panel Q & A
11 Refreshment break
11:15

Phase 1 Units in Neuroscience
Angela Genge, MD, FRCP
Director, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada

Kristiana Salmon, BSc, EMBA
Assistant Manager, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada

12:30

Closing Remarks
Dr. Angela Genge

12:35 Lunch & Networking

Hotels

McGill University has agreements for special rates with several other downtown hotels.

Follow this link to see the selection.

Organizing Committee

Angela Genge

Maxime Boutin-Caron

Debbie Rashcovsky

Contact

Debbie Rashcovsky
Events Officer

Director's Office
Montreal Neurological Institute
3801 University Street, room 684
Montreal, Quebec H3A 2B4

Tel: 514-398-6047
Cell: 514-971-6047
Email: debbie.rashcovsky [at] mcgill.ca

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

The Neuro is a McGill research and teaching institute; delivering the highest quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.